Accession Number:

ADA504710

Title:

A Randomized Placebo-Controlled Trial of Citalopram for Anxiety Disorders Following Traumatic Brain Injury

Descriptive Note:

Annual rept. 1 Apr 2007-31 Mar 2008

Corporate Author:

HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE ROCKVILLE MD

Personal Author(s):

Report Date:

2008-04-01

Pagination or Media Count:

5.0

Abstract:

The overarching goal of this project is to study the effects of a serotonin reuptake inhibitor SRI, citalopram, for the treatment of anxiety experienced by individuals after traumatic brain injury TBI. Specifically, this project seeks to treat individuals who meet criteria for DSM-IV diagnosis of Anxiety Disorder Due to a General Medical Condition, within 3 to 24 months of TBI. A randomized placebo controlled design with 1-year follow-up will be utilized to evaluate the effectiveness of citalopram in alleviating significant anxiety symptoms that cause significant distress and can lead to medical retirement of active duty soldiers.

Subject Categories:

  • Psychology
  • Anatomy and Physiology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE